EWTX
Edgewise Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -14.3% ·
share flow -24.1% ·
net new positions -16.7%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | +9 | 40.35M | $1.62B | +14 | −4 |
| Q1 2026 | 81 | +4 | 39.90M | $1.24B | +9 | −6 |
| Q4 2025 | 77 | +2 | 40.83M | $1.01B | +3 | n/a |
| Q3 2025 | 14 | +1 | 17.98M | $291.62M | +1 | −1 |
| Q2 2025 | 11 | -4 | 17.73M | $232.39M | n/a | −4 |
| Q1 2025 | 12 | -2 | 5.61M | $123.36M | n/a | −2 |
| Q4 2024 | 14 | 0 | 7.38M | $197.14M | +1 | −1 |
| Q3 2024 | 13 | +3 | 6.24M | $166.42M | +3 | n/a |
| Q2 2024 | 10 | n/a | 8.30M | $149.57M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.72M | +0.1% | $37.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.66M | +3.4% | $36.43M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Millennium Management ✦ | 615.12K | -30.8% | $13.53M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Viking Global Investors ✦ | 490.04K | -60.0% | $10.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Adage Capital Partners ✦ | 390.00K | +62.5% | $8.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 294.88K | +915.1% | $6.49M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 140.55K | -79.5% | $3.09M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 113.30K | -44.2% | $2.49M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 9 | Citadel Advisors ✦ | 97.28K | -79.3% | $2.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Norges Bank ✦ (passive) | 47.76K | 0.0% | $1.05M | 0.0% | Held | 3 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 35.00K | -73.4% | $769,978 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 9.42K | +0.6% | $207,218 | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Point72 Asset Management | $2.85M | was 0.0% |
| Marshall Wace | $798,142 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 213 holders, 118.39M shares, $3.71B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.92K sh · $126,704
Officer · 2.17K sh · $95,075
Officer · 304 sh · $13,529
Officer · 150 sh · $6,666
Officer · 2.48K sh · $108,154
Officer · 2.84K sh · $124,303
Officer · 2.78K sh · $121,463
Officer · 104 sh · $4,620
Officer · 800 sh · $35,614
Officer, Director · 8.28K sh · $361,315
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology